Last reviewed · How we verify
Placebo + aerobic exercise — Competitive Intelligence Brief
marketed
Cardiovascular, Metabolic
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo + aerobic exercise (Placebo + aerobic exercise) — University of Göttingen. Placebo combined with aerobic exercise improves cardiovascular and metabolic health through physical conditioning and the placebo effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo + aerobic exercise TARGET | Placebo + aerobic exercise | University of Göttingen | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo + aerobic exercise CI watch — RSS
- Placebo + aerobic exercise CI watch — Atom
- Placebo + aerobic exercise CI watch — JSON
- Placebo + aerobic exercise alone — RSS
Cite this brief
Drug Landscape (2026). Placebo + aerobic exercise — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-aerobic-exercise. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab